Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
37909
CAS Number:
21187-98-4
Gliclazide
Purity:
≥ 98,5 % (dosage par titration, HPLC)
Synonym(s):
1-[3-Azabicyclo[3.3.0]oct-3-yl]-3- p- toluènesulfonylurée
Documents
$77.92 /5G
Taille
Request Bulk Quote
Informations sur le produit

Gliclazide is a sulfonylurea derivative widely utilized in the management of type 2 diabetes mellitus. This compound functions primarily by stimulating insulin secretion from the pancreatic beta cells, thereby effectively lowering blood glucose levels. Its unique structure allows for a prolonged action, making it a preferred choice in diabetes treatment regimens. Gliclazide not only enhances insulin sensitivity but also exhibits antioxidant properties, which can contribute to cardiovascular health in diabetic patients.

In addition to its primary use in diabetes management, Gliclazide has shown potential in research settings for exploring its effects on metabolic syndrome and its role in improving glycemic control. Its favorable pharmacokinetic profile and lower risk of hypoglycemia compared to other sulfonylureas make it an attractive option for healthcare professionals. With its proven efficacy and safety, Gliclazide continues to be a vital component in diabetes care, offering patients a reliable means to manage their condition effectively.

Numéro CAS 
21187-98-4
Formule moléculaire
C15H21N3O3S
Poids moléculaire 
323.41
Point de fusion 
160 - 169 °C
Informations générales
Numéro CAS 
21187-98-4
Formule moléculaire
C15H21N3O3S
Poids moléculaire 
323.41
Point de fusion 
160 - 169 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Gliclazide is widely utilized in research focused on:

  • Diabetes Management: Primarily used as an oral hypoglycemic agent, it helps control blood sugar levels in patients with type 2 diabetes, making it essential for endocrinology practices.
  • Pharmaceutical Development: Researchers explore its mechanisms and efficacy, contributing to the development of new diabetes medications and improving existing treatment protocols.
  • Clinical Trials: Frequently involved in clinical studies to assess its effectiveness and safety, providing valuable data for healthcare professionals and regulatory bodies.
  • Combination Therapies: Often used in conjunction with other antidiabetic agents, enhancing overall glucose control and offering a more comprehensive treatment approach for patients.
  • Patient Education: Used in educational programs for diabetes management, helping patients understand the importance of medication adherence and lifestyle changes for better health outcomes.

Citations